IFNA1 and neoplasm: Further investigation has revealed that this enhancement is largely attributed to an increase in IFN levels, causing a shift from a Th2 immunophenotype to a Th1 immunophenotype, thereby boosting anti-tumor capabilities (Wörmann et al., 2014).